Literature DB >> 6723753

Acute haemodynamic effects of ajmaline and prajmaline in patients with coronary heart disease.

E Sowton, I D Sullivan, J C Crick.   

Abstract

Thirty patients undergoing cardiac catheterisation for coronary artery disease received parenteral ajmaline (15 patients) or prajmaline (15 patients). There were no statistically significant induced changes in left ventricular systolic or end diastolic pressures, indirect left atrial pressure, pulmonary artery mean pressure, cardiac output or left ventricular ejection fraction compared to control values. Intravenous prajmaline bitartrate in 15 patients with angina did not significantly alter work capacity, maximum exercise heart rate or systolic blood pressure compared to control values. Five patients developed transient minor conduction defects ( 2LBBB , 1 RBBB, 2 prolonged PR interval): all five were also receiving long-term treatment with beta blockers and nifedipine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6723753     DOI: 10.1007/BF00630278

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome.

Authors:  H J Wellens; D Durrer
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

2.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man.

Authors:  H Sandler; H T Dodge
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

3.  Orally administered prajmalium bitartrate in acute and chronic ventricular arrhythmias.

Authors:  W D Bussmann; E Müller; H J Hänel; M Kaltenbach
Journal:  Am J Cardiol       Date:  1978-03       Impact factor: 2.778

4.  Hemodynamic effects of repeated exercise.

Authors:  F Burkart; S Barold; E Sowton
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

5.  Cardiovascular effects of ajmaline.

Authors:  K Obayashi; K Nagasawa; W J Mandel; J K Vyden; W W Parmley
Journal:  Am Heart J       Date:  1976-10       Impact factor: 4.749

  5 in total
  2 in total

1.  Verapamil pharmacokinetics and apparent hepatic and renal blood flow.

Authors:  P A Meredith; H L Elliott; F Pasanisi; A W Kelman; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

2.  Effects of oral prajmaline bitartrate on exercise test responses in patients with coronary artery disease.

Authors:  C E Handler; A Kritikos; I D Sullivan; A Charalambakis; E Sowton
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.